Translated automatically – community improvements welcome.
Adrafinil
Adrafinil is a wakefulness-promoting agent that is metabolized in the body to Modafinil. It primarily affects dopamine and norepinephrine transporters, leading to increased alertness and concentration. The substance is used to treat sleep disorders but carries potential risks for the liver and cardiovascular system with prolonged use.
Mechanism of Action
- Dopamin transporter inhibitor
- Noradrenalin transporter inhibitor
Names / Identifiers
IUPAC: Adrafinil
Mechanism of Action
Adrafinil is metabolized in the body to Modafinil, which inhibits the reuptake of dopamine and norepinephrine. This leads to increased alertness and concentration.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Not recommended for cardiovascular diseases.
- Caution in anxiety disorders.
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Schlaflosigkeit, Nervosität und erhöhter Blutdruck.
Safer Use
- Start at a low dose.
- Be aware of possible interactions with other stimulants.
Harm reduction tips do not replace medical advice.
Known Interactions
- May interact with other stimulants.
- Caution with concurrent use of MAO inhibitors.
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.
Gemeinsame Wirkungsmuster
Wirkungen, die Adrafinil mit verwandten Substanzen teilt.